Received Aug 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
back today to start the completion of the series; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 67-year-old female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (received 1st dose on 20-FEB-2019). On an unknown date, the patient did not receive the 2nd dose of Twinrix. The patient experienced incomplete course of vaccination (Verbatim: back today to start the completion of the series). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-JUL-2025 The pharmacist reported that the patient received 1st dose of Twinrix on 20-FEB-2019 and was back on the day of reporting to start the completion of the series. The pharmacist was unsure if patient had received 2 doses or just the 1 dose, how should they proceed with completing the series for the patient. Patient had not received next dose of Twinrix at the time of the reporting. Till the time of reporting, the patient did not receive 2nd dose of Twinrix vaccine, which led to incomplete course of vaccination.